Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.
November 01, 2021
Share
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Huang Zhiyong and Huang Libing for approximately CNY 210 million on November 2, 2021. Under the terms Liu Libiao will acquire 25.5 million shares for CNY 8.38 per share. Liu Libiao will transfer VNY 63 million and CNY 2 million to account designated byHuang Zhiyong and Huang Libing respectively as deposits. The total deposit of CNY 65 million paid by Party B above will be converted into contract payment after the completion of the transfer of shares. The remaining amount is CNY 148.7 million will be transferred to designated accounts. Huang Zhiyong transfers 24,997,848 shares, accounting for 4.93% of the total share capital and Huang Libing transfers 507248 shares, accounting for 0.10% of the total share capital of Guangdong Jiaying Pharmaceutical Co., Ltd. Before this share transfer, Huang Zhiyong held 24.99 million shares of the company, accounting for 4.93% of and Huang Libing held 0.70 million shares, accounting for 0.14% . Liu Libiao did not hold any company shares . After this share transfer, Huang Zhiyong no longer holds the company?s shares, Huang Libing holds 200,000 shares, accounting for 0.04% of the company?s total share capital and Liu Libiao holds 5.03% stake of Guangdong Jiaying Pharmaceutical Co., Ltd.
GUANGDONG JIAYING PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent medicine. The Companyâs main products include Chinese traditional preparations, powders, tablets, capsules and granules, which are mainly applied in the treatment of throat disease, cold, stomach disease and others, as well as for tonic nourish purpose and others. The Company distributes its products mainly in domestic market. Through its subsidiaries, the Company is also engaged in the operation and leasing of self-owned real estate.
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.